Actively Recruiting
Acute Partial Thickness Burn Study Comparing Transforming Powder Dressing to Standard of Care Dressing
Led by ULURU Inc. · Updated on 2025-11-19
60
Participants Needed
6
Research Sites
226 weeks
Total Duration
On this page
Sponsors
U
ULURU Inc.
Lead Sponsor
N
Navy Advanced Medical Development (NAMD) Command
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study is being performed to assess the effectiveness of Altrazeal(R) Transforming Powder Dressing (TPD) in patients with partial thickness burns compared to the current standard of care (SOC) dressing. Adult men and women 18-65 years old who are hospitalized with an acute (meaning the burn injury occurred less than 72 hours prior to enrollment in the study) partial thickness burn wound, less than 20 percent of total body surface area may be considered. Subjects will be randomized in a 1:1 ratio to either SOC or TPD. Subjects will be followed for up to 28 days after enrollment.
CONDITIONS
Official Title
Acute Partial Thickness Burn Study Comparing Transforming Powder Dressing to Standard of Care Dressing
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Hospitalized patients receiving burn care, with possible outpatient continuation after discharge
- Men and women aged 18 to 65 years (women must not be pregnant or breastfeeding)
- Partial thickness burn wounds involving up to 20% of total body surface area
- Burn injury occurred less than 72 hours before enrollment
- Willing and able to comply with scheduled study visits and evaluations
- Able to provide written informed consent
You will not qualify if you...
- Known allergy to Transforming Powder Dressing or its components
- Women who are pregnant, breastfeeding, or planning pregnancy during the study
- Infected burn wounds
- Presence of any full thickness (third degree) burns
- Electrical burns
- Heavily draining burns due to chronic lymphedema or other causes
- Clinical conditions posing health risks, delaying healing, or affecting study outcome as judged by clinician
- History of poor wound healing or skin/immune system conditions
- Clinician deems participant unsuitable
- Unable or unwilling to provide consent or comply with study visits
- Developmental disability or psychological disorder impairing consent or participation
- Active alcohol or substance abuse
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 6 locations
1
University of California-Irvine
Orange, California, United States, 92868
Actively Recruiting
2
MedStar Washington Hospital Center
Washington D.C., District of Columbia, United States, 20010
Actively Recruiting
3
Jackson Memorial Hospital UM/JMH Burn Center
Miami, Florida, United States, 33136
Actively Recruiting
4
University of Louisville Health
Louisville, Kentucky, United States, 40202
Actively Recruiting
5
Westchester Medical Center
Valhalla, New York, United States, 10595
Actively Recruiting
6
University of Texas SW (Parkland)
Dallas, Texas, United States, 75235
Actively Recruiting
Research Team
V
Vai Shah
CONTACT
S
Susan St John, MSN
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here